Sweden· SE-19991217000045
Grafalon 20 mg/ml Koncentrat till infusionsvätska, lösning
A medicinal product containing anti-t lymphocyte immunoglobulin for human use + rabbit, registered in Sweden by Neovii Biotech GmbH.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Anti-T Lymphocyte Immunoglobulin For Human Use + Rabbit
- Manufacturer
- Neovii Biotech GmbH
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19991217000045
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf886801-7689-443e-beaf-a5452f7e1ac3 GET /v1/drugs/bf886801-7689-443e-beaf-a5452f7e1ac3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "19991217000045",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19991217000045",
"product_doc_link": "https://docetp.mpa.se/LMF/Grafalon%20concentrate%20for%20solution%20for%20infusion%20SmPC_09001bee807a3fde.pdf"
}See everything about anti-t lymphocyte immunoglobulin for human use + rabbit.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.